Bg pattern

ARCOXIA 90 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use ARCOXIA 90 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

ARCOXIA 30mg film-coated tablets

ARCOXIA 60mg film-coated tablets

ARCOXIA 90mg film-coated tablets

ARCOXIA 120mg film-coated tablets

etoricoxib

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is ARCOXIA and what is it used for
  2. What you need to know before you take ARCOXIA
  3. How to take ARCOXIA
  4. Possible side effects
  5. Storage of ARCOXIA
  6. Contents of the pack and other information

1. What is ARCOXIA and what is it used for

What is Arcoxia?

  • Arcoxia contains the active substance etoricoxib. Arcoxia belongs to a group of medicines called selective COX-2 inhibitors. These belong to a family of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).

What is Arcoxia used for?

  • Arcoxia helps to reduce pain and swelling (inflammation) in the joints and muscles in people 16 years of age and older with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and gout.
  • Arcoxia is also used for the short-term treatment of moderate pain after dental surgery in people 16 years of age and older.

What is osteoarthritis?

Osteoarthritis is a disease of the joints. It leads to the breakdown of cartilage, the tissue that cushions the ends of the bones. This causes swelling (inflammation), pain, tenderness, stiffness and disability.

What is rheumatoid arthritis?

Rheumatoid arthritis is a long-term inflammatory disease of the joints. It causes pain, stiffness, swelling and progressive loss of movement in the affected joints. It also causes inflammation in other areas of the body.

What is gout?

Gout is a disease characterized by sudden, recurring attacks of very painful inflammation and redness in the joints. It is caused by deposits of mineral crystals in the joint.

What is ankylosing spondylitis?

Ankylosing spondylitis is an inflammatory disease of the spine and large joints.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take ARCOXIA

Do not take Arcoxia

  • if you are allergic (hypersensitive) to etoricoxib or any of the other ingredients of this medicine (listed in section 6)
  • if you are allergic to non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin and COX-2 inhibitors (see Possible side effects, section 4)
  • if you currently have an ulcer or bleeding in your stomach or duodenum
  • if you have severe liver disease
  • if you have severe kidney disease
  • if you are or may be pregnant, or are breast-feeding (see "Pregnancy, breast-feeding and fertility")
  • if you are under 16 years of age
  • if you have inflammatory bowel disease, such as Crohn's disease, ulcerative colitis or colitis
  • if you have high blood pressure that is not well-controlled with treatment (check with your doctor or nurse if you are not sure if your blood pressure is well-controlled)
  • if your doctor has diagnosed heart problems, including heart failure (moderate or severe), angina (chest pain)
  • if you have had a heart attack, bypass surgery, peripheral artery disease (poor circulation in your legs or feet due to narrow or blocked arteries)
  • if you have had any kind of stroke (including mini-stroke or transient ischaemic attack).

Etoricoxib may slightly increase your risk of heart attack and stroke, and this risk is higher in patients who already have heart disease or have had a stroke. Therefore, it should not be used in patients who have had heart problems or a stroke.

If you think any of these are relevant to you, do not take the tablets until you have spoken to your doctor.

Warnings and precautions

Consult your doctor or pharmacist before taking Arcoxia if:

  • You have had stomach ulcers or bleeding.
  • You are dehydrated, for example due to prolonged vomiting or diarrhoea.
  • You have swelling due to fluid retention.
  • You have a history of heart failure or any other form of heart disease.
  • You have a history of high blood pressure. Arcoxia may increase blood pressure in some people, especially at high doses, and your doctor will want to check your blood pressure from time to time.
  • You have a history of liver or kidney disease.
  • You are being treated for an infection. Arcoxia may mask or hide fever, which is a sign of infection.
  • You have diabetes, high cholesterol or are a smoker, as these may increase your risk of heart disease.
  • You are a woman trying to become pregnant.
  • You are over 65 years of age.

If you are not sure if any of the above apply to you, talk to your doctor before taking Arcoxiato check if this medicine is suitable for you.

Arcoxia works just as well in older and younger adult patients. If you are over 65 years of age, your doctor will want to keep a closer check on you. No dose adjustment is necessary for patients over 65 years of age.

Children and adolescents

Do not give this medicine to children and adolescents under 16 years of age.

Other medicines and Arcoxia

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including those obtained without a prescription.

In particular, if you are taking any of the following medicines, your doctor may want to check that your medicines are working properly once you start taking Arcoxia:

  • medicines that thin your blood (anticoagulants), such as warfarin
  • rifampicin (an antibiotic)
  • methotrexate (a medicine used to suppress the immune system and often used in rheumatoid arthritis)
  • ciclosporin or tacrolimus (medicines used to suppress the immune system)
  • lithium (a medicine used to treat some types of depression)
  • medicines used to help control high blood pressure and heart failure, called ACE inhibitors and angiotensin receptor blockers, for example enalapril and ramipril, and losartan and valsartan
  • diuretics (water tablets)
  • digoxin (a medicine for heart failure and irregular heartbeat)
  • minoxidil (a medicine used to treat high blood pressure)
  • tablets or oral solution of salbutamol (a medicine for asthma)
  • oral contraceptives (the combination may increase your risk of side effects)
  • hormone replacement therapy (the combination may increase your risk of side effects)
  • aspirin, the risk of stomach ulcers is greater if you take Arcoxia with aspirin.
  • Aspirin for the prevention of heart attacks or stroke:

Arcoxia can be taken with low dosesof aspirin. If you are currently taking low doses of aspirin to prevent heart attacks or stroke, do not stop taking aspirin until you talk to your doctor

  • Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs):

do not take high dosesof aspirin or other anti-inflammatory medicines while taking Arcoxia.

Taking Arcoxia with food and drink

The onset of effect of Arcoxia may be faster if taken without food.

Pregnancy, breast-feeding and fertility

Pregnancy

Arcoxia tablets should not be taken during pregnancy. Do not take the tablets if you are pregnant, think you may be pregnant or are planning to get pregnant. If you become pregnant, stop taking the tablets and consult your doctor. Consult your doctor if you have any doubts or need more information.

Breast-feeding

It is not known if Arcoxia passes into breast milk. If you are breast-feeding or planning to breast-feed, consult your doctor before taking Arcoxia. If you are taking Arcoxia, you should not breast-feed.

Fertility

Arcoxia should not be used in women who are trying to become pregnant.

Driving and using machines

In some patients taking Arcoxia, dizziness and somnolence have been reported.

Do not drive if you experience dizziness or somnolence.

Do not use tools or machines if you experience dizziness or somnolence.

Arcoxia contains lactose

This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult your doctor before taking this medicine.

Arcoxia contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per film-coated tablet; this is essentially "sodium-free".

3. How to take ARCOXIA

Follow exactly the instructions given to you by your doctor. In case of doubt, consult your doctor or pharmacist again.

Do not take more than the recommended dose for your condition. Your doctor will want to discuss your treatment from time to time. It is important that you use the lowest dose that controls your pain and you should not take Arcoxia for longer than necessary. This is because the risk of heart attacks and strokes might increase after long-term treatment, especially with high doses.

There are different doses available for this medicine, and depending on your disease, your doctor will prescribe the tablet with the dose that is right for you.

The recommended dose is:

Osteoarthritis

The recommended dose is 30 mg once daily, increased to a maximum of 60 mg once daily if needed.

Rheumatoid arthritis

The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily if needed.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

Ankylosing spondylitis

The recommended dose is 60 mg once daily, increased to a maximum of 90 mg once daily if needed.

Acute pain situations

Etoricoxib should only be used for the period of acute pain.

Gout

The recommended dose is 120 mg once daily, which should only be used during the acute painful period, limited to a maximum of 8 days of treatment.

Post-operative dental pain

The recommended dose is 90 mg once daily, limited to a maximum of 3 days of treatment.

Patients with liver problems

  • If you have mild liver disease, you should not take more than 60 mg per day.
  • If you have moderateliver disease, you should not take more than 30mg per day.

Use in children and adolescents

Children or adolescents under 16 years of age should not take Arcoxia tablets.

Patients over 65 years of age

No dose adjustment is necessary for patients over 65 years of age. As with other medicines, caution should be exercised in elderly patients.

Method of administration

Arcoxia is administered orally. Take the tablets once daily. Arcoxia can be taken with or without food.

If you take more Arcoxia than you should

Never take more tablets than your doctor recommends. If you take too many Arcoxia tablets, seek medical attention immediately.

In case of overdose or accidental ingestion, you can also contact the Toxicology Information Service, Tel. 91 562 04 20, stating the medicine and the amount taken. It is recommended to take the packaging and the leaflet of the medicine to the healthcare professional.

If you forget to take Arcoxia

It is important that you take Arcoxia as your doctor has instructed. If you forget a dose, just resume your normal schedule the next day. Do not take a double dose to make up for forgotten doses.

If you have any other questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you develop any of these signs, stop taking Arcoxia and speak to your doctor immediately (see section 2. What you need to know before you take Arcoxia):

  • difficulty breathing, chest pain or ankle swelling, or if these get worse
  • yellowing of the skin and eyes (jaundice) - these are signs of liver problems
  • severe stomach pain or persistent vomiting, or if your stools become black
  • an allergic reaction - which can include skin problems such as ulcers or blistering, or swelling of the face, lips, tongue or throat which may cause difficulty in breathing

The frequency of possible side effects listed below is defined using the following convention:

Very common (may affect more than 1 in 10 people)

Common (may affect up to 1 in 10 people)

Uncommon (may affect up to 1 in 100 people)

Rare (may affect up to 1 in 1,000 people)

Very rare (may affect up to 1 in 10,000 people)

The following side effects may occur during treatment with Arcoxia:

Very common:

  • stomach pain

Common:

  • alveolar osteitis (inflammation and pain after tooth extraction)
  • swelling of the legs and/or feet due to fluid retention (edema)
  • dizziness, headache
  • palpitations (fast or irregular heartbeat), irregular heartbeat (arrhythmia)
  • high blood pressure
  • wheezing or shortness of breath (bronchospasm)
  • constipation, gas (excess gas), gastritis (inflammation of the stomach lining), heartburn, diarrhea, indigestion (dyspepsia)/stomach upset, nausea, vomiting, esophagitis, mouth ulcers
  • changes in blood tests related to your liver
  • bruising
  • weakness and fatigue, flu-like illness

Uncommon:

  • gastroenteritis (inflammation of the gastrointestinal tract that affects both the stomach and the small intestine/common cold), cold, urinary tract infection
  • changes in laboratory results (decreased red blood cells, decreased white blood cells, decreased platelets)
  • hypersensitivity (allergic reaction including hives that may be severe enough to require immediate medical attention)
  • increased or decreased appetite, weight gain
  • anxiety, depression, decreased mental sharpness; seeing, hearing or feeling things that are not there (hallucinations)
  • altered taste, insomnia, numbness or tingling, somnolence
  • blurred vision, eye irritation and redness
  • ringing in the ears, vertigo (feeling of spinning while standing still)
  • abnormal heartbeat (atrial fibrillation), fast heartbeat, heart failure, feeling of tension, pressure or heaviness in the chest (angina pectoris), heart attack
  • flushing, stroke, mini-stroke (transient ischaemic attack), severe increase in blood pressure, inflammation of blood vessels
  • cough, shortness of breath, nosebleed
  • stomach swelling, changes in bowel movements, dry mouth, stomach ulcer, inflammation of the stomach lining that can be severe and can cause bleeding, irritable bowel syndrome, pancreatitis
  • swelling of the face, skin rash or itching
  • muscle cramp/spasm, muscle pain/stiffness
  • high levels of potassium in your blood, changes in blood or urine tests related to your kidneys, severe kidney problems
  • chest pain

Rare:

  • angioedema (allergic reaction with swelling of the face, lips, tongue and/or throat that can cause difficulty breathing or swallowing, which can be severe enough to require immediate medical attention)/anaphylactic/anaphylactoid reactions including shock (severe allergic reaction that requires immediate medical attention)
  • confusion, nervousness
  • liver problems (hepatitis)
  • low levels of sodium in the blood
  • liver disorder, yellowing of the skin and/or eyes (jaundice)
  • severe skin reactions

Reporting of side effects:If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of ARCOXIA

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton. The expiry date is the last day of the month indicated.

Bottles: keep the container tightly closed to protect from moisture.

Blister packs: store in the original package to protect from moisture.

Medicines should not be disposed of via wastewater or household waste. Dispose of the packaging and any unused medicine in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and unused medicine. This will help protect the environment.

6. Package contents and additional information

Composition ofArcoxia

  • The active substance is etoricoxib. Each film-coated tablet contains 30, 60, 90 or 120 mg of etoricoxib.
  • The other ingredients are:

Core of the tablet: hydrogenated calcium phosphate (anhydrous), sodium croscarmellose, magnesium stearate, microcrystalline cellulose.

Coating of the tablet: carnauba wax, lactose monohydrate, hypromellose, titanium dioxide (E-171), triacetin. The 30, 60 and 120 mg tablets also contain yellow iron oxide (E-172, coloring agent) and carmine indigo lake (E-132, coloring agent).

Appearance and package contents of the product

Arcoxia tablets are available in four doses:

Film-coated tablets of 30 mg, blue-green, apple-shaped, biconvex, engraved with 'ACX 30' on one side and '101' on the other.

Film-coated tablets of 60 mg, dark green, apple-shaped, biconvex, engraved with 'ARCOXIA 60' on one side and '200' on the other.

Film-coated tablets of 90 mg, white, apple-shaped, biconvex, engraved with 'ARCOXIA 90' on one side and '202' on the other.

Film-coated tablets of 120 mg, pale green, apple-shaped, biconvex, engraved with 'ARCOXIA 120' on one side and '204' on the other.

30 mg:

Package sizes of 2, 7, 14, 20, 28, 49, 98 tablets or multi-packs containing 98 (2 packs of 49) tablets in blisters.

60 mg:

Package sizes of 2, 5, 7, 10, 14, 20, 28, 30, 50, 84, 98, 100 tablets or multi-packs containing 98 (2 packs of 49) tablets in blisters; or 30 and 90 tablets in bottles with desiccant. The desiccant (one or two packets) in the bottle, used to keep the tablets dry, should not be swallowed.

90 mg:

Package sizes of 2, 5, 7, 10, 14, 20, 28, 30, 50, 84, 98, 100 tablets or multi-packs containing 98 (2 packs of 49) tablets in blisters; or 30 and 90 tablets in bottles with desiccant. The desiccant (one or two packets) in the bottle, used to keep the tablets dry, should not be swallowed.

120 mg:

Package sizes of 2, 5, 7, 10, 14, 20, 28, 30, 50, 84, 100 tablets or multi-packs containing 98 (2 packs of 49) tablets in blisters; or 30 and 90 tablets in bottles with desiccant. The desiccant (one or two packets) in the bottle, used to keep the tablets dry, should not be swallowed.

60, 90 and 120 mg:

Aluminum/aluminum blister packs (unit dose) in packs of 5, 50 or 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Organon Health, S.L.

Paseo de la Castellana, 77

28046 Madrid

Spain

Tel.: 915911279

Manufacturer

Merck Sharp & Dohme B.V.

Waarderweg 39

2031 BN Haarlem

Netherlands

or

Vianex, S.A. (only for Greece)

15th Km Av. Marathonos Ave.

15351 Pallini Attikis,

Athens

Greece

or

Organon Heist bv

Industriepark 30

2220 Heist-op-den-Berg

Belgium

This medicinal product is authorized in the Member States of the European Economic Area under the following names:

Belgium, Luxembourg

Arcoxia 30 mg, 60 mg, 90 mg, 120 mg, film-coated tablets

Denmark, Estonia, Iceland, Norway

Arcoxia

Ireland, United Kingdom

Austria

Czech Republic

Cyprus, Malta

Finland

France

Germany

Greece

Hungary

Italy

Latvia

Lithuania

ARCOXIA 30, 60, 90 or 120 mg film-coated tablets

Arcoxia 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets

ARCOXIA 30 mg, 60 mg, 90 mg coated tablets

ARCOXIA 60, 90, 120 mg film-coated tablets

Arcoxia 30, 60, 90 and 120 mg film-coated tablets

ARCOXIA 30, 60 mg, film-coated tablets

ARCOXIA 30/60/90/120 mg film-coated tablets

ARCOXIA 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets

Arcoxia 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets

ARCOXIA 30, 60, 90, 120 mg film-coated tablets

Arcoxia 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets

Netherlands

Arcoxia 30 mg, 60 mg, 90 mg, 120 mg, film-coated tablets

Poland

ARCOXIA 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets

Portugal

ARCOXIA 30 mg, 60 mg, 90 mg, 120 mg film-coated tablets

Slovakia

ARCOXIA 30 mg, 60 mg, 90 mg, 120 mg

Slovenia

Arcoxia 30/60/90/120 mg film-coated tablets

Spain

ARCOXIA 30, 60, 90 and 120 mg film-coated tablets

Sweden

Arcoxia 30 mg, 60 mg, 90 mg and 120 mg film-coated tablets

Date of last revision of this leaflet:05/2021.

Detailed and up-to-date information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

Online doctors for ARCOXIA 90 mg FILM-COATED TABLETS

Discuss questions about ARCOXIA 90 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for ARCOXIA 90 mg FILM-COATED TABLETS?
ARCOXIA 90 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in ARCOXIA 90 mg FILM-COATED TABLETS?
The active ingredient in ARCOXIA 90 mg FILM-COATED TABLETS is etoricoxib. This information helps identify medicines with the same composition but different brand names.
How much does ARCOXIA 90 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for ARCOXIA 90 mg FILM-COATED TABLETS is around 16.11 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures ARCOXIA 90 mg FILM-COATED TABLETS?
ARCOXIA 90 mg FILM-COATED TABLETS is manufactured by Organon Salud S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of ARCOXIA 90 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether ARCOXIA 90 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to ARCOXIA 90 mg FILM-COATED TABLETS?
Other medicines with the same active substance (etoricoxib) include ACOXXEL 120 mg FILM-COATED TABLETS, ACOXXEL 30 mg FILM-COATED TABLETS, ACOXXEL 60 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media